COMPOSITION:
Each 5 ml contains:
|
Levocetirizine Dihydrochloride |
I.P. |
5 mg |
|
Ambroxol hydrochloride |
I.P. |
30 mg |
|
In a flavored mentholated syrupy base |
|
|
|
Colour: Tartrazine and brilliant blue FCF |
|
|
DESCRIPTION:
Ambroxol is the metabolite of bromhexine and a mucolytic agent. Ambroxol acts as secretolytic agent used in the treatment of respiratory diseases associated with viscid or excessive mucus. Levocetirizine dihydrochloride is the R enantiomer of cetirizine hydrochloride, a racemic compound with antihistaminic properties.
MECHANISM OF ACTION:
Ambroxol facilitates mucociliary clearance by intensifying the motion of the cilia present on the ciliated respiratory epithelium. Levocetirizine, the active enantiomer of cetirizine, is an antihistamine; its principal effects are mediated via selective inhibition of H1 receptors. In vitro binding studies revealed that levocetirizine has an affinity for the human H1-receptor 2-fold higher than cetirizine (Ki = 3 nmol/L vs. 6 nmol/L, respectively).
INDICATIONS:
Indicated for the treatment of whooping cough, post-surgical cough, dry cough, smokers cough, and chronic cough.
CONTRAINDICATIONS:
Hypersensitivity to any of the ingredients of the product.
DOSAGE:
As directed by the physician.
STORAGE:
Store in a cool and dry place. Recap the bottle tightly after use.
PRESENTATION:
100 ml
SHAKE WELL BEFORE USE
BARCODE:
0108906044105430
0118906044105437
0128906044105434
